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Abstract 
Over half of our genome is composed of retrotransposons, which are mobile elements that can readily amplify  
their copy number by replicating through an RNA intermediate. Most of these elements are no longer mobile but 
still contain regulatory sequences that can serve as promoters, enhancers or repressors for cellular genes. Despite 
dominating our genetic content, little is known about the precise functions of retrotransposons, which include both 
endogenous retroviruses (ERVs) and non‑LTR elements like long interspersed nuclear element 1 (LINE‑1). However, 
a few recent cutting‑edge publications have illustrated how retrotransposons shape species‑specific stem cell gene 
expression by two opposing mechanisms, involving their recruitment of stem cell‑enriched transcription factors (TFs): 
firstly, they can activate expression of genes linked to naïve pluripotency, and secondly, they can induce repression  
of proximal genes. The paradox that different retrotransposons are active or silent in embryonic stem cells (ESCs) can  
be explained by differences between retrotransposon families, between individual copies within the same family,  
and between subpopulations of ESCs. Since they have coevolved with their host genomes, some of them have been  
co‑opted to perform species‑specific beneficial functions, while others have been implicated in genetic disease.  
In this review, we will discuss retrotransposon functions in ESCs, focusing on recent mechanistic advances of how 
HERV‑H has been adopted to preserve human naïve pluripotency and how particular LINE‑1, SVA and ERV family 
members recruit species‑specific transcriptional repressors. This review highlights the fine balance between activation 
and repression of retrotransposons that exists to harness their ability to drive evolution, while minimizing the risk they 
pose to genome integrity.
© 2015 Robbez‑Masson and Rowe. This article is distributed under the terms of the Creative Commons Attribution 4.0 Interna‑
tional License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in 
any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Com‑
mons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecom‑
mons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Part I: Retrotransposons are active in ESCs
Retrotransposon activity fluctuates between distinct 
embryonic cell states
Retrotransposons, which may encompass over two-
thirds of the human genome [1] have the potential to 
cause insertional mutagenesis or transcriptional pertur-
bation prompting their epigenetic silencing during early 
embryonic development. Retrotransposons are then 
assumed to remain inactive throughout the organism’s 
adult life through their collective DNA methylation and 
their aberrant activation has been associated with can-
cer and autoimmune disorders [2, 3]. However, it has 
long been known that these elements also play normal 
roles in development, particularly in the placenta. A 
series of papers have now revealed that subsets of ret-
rotransposons are expressed within mouse and human 
embryonic stem cell (ESC) cultures. The roles that these 
retrotransposons may play in development relate to 
their distinct expression patterns between different in 
vitro subpopulations of ESCs that are described below.
Embryonic stem cells are characterised by their capac-
ity for self-renewal and pluripotency. They constitute 
a category of primary cells isolated from the inner cell 
mass (ICM) of blastocysts, which are early-stage pre-
implantation embryos, and these cells can form tightly 
aggregated, three-dimensional colonies in culture. ESCs 
have been used as model systems to study the pluripo-
tent state and the conditions required for cellular differ-
entiation. Indeed, ESCs possess the remarkable capacity 
to self-renew and differentiate into cells of all three germ 
layers of the embryo (endoderm, mesoderm and ecto-
derm) including the germ line in vitro, or in vivo when 
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ESCs are injected into blastocysts leading to the genera-
tion of chimeric mice [4].
Cultures of mouse ESCs display a great degree of 
intercellular heterogeneity, where cells can exhibit dif-
ferent states of pluripotency (as shown by their dif-
ferent gene expression profiles [5]). Cells within these 
cultures are dynamic, shuttling between a ground state 
termed “naïve” and a more committed “primed” state 
[6–8]. Hallmarks of naïve stem cells include high and 
stable expression of core pluripotency-associated TFs 
such as NANOG, OCT4 (POU5F1), the active Oct4 dis-
tal enhancer, REX1, and SOX2. Moreover, these cells 
express key naïve (or ground-state) defining TFs, such 
as LBP9 and KLF4. Naïve cells also display global DNA 
hypomethylation, an absence of chromosome X inactiva-
tion and a reduced concentration of H3K27me3 repres-
sive histone marks on the main developmental genes [7, 
9]. Such ground state ESCs can be maintained in two-
inhibitor (2i) medium supplemented with Leukaemia 
inhibitory factor (LIF). 2i culture conditions involve 
the addition of two specific small molecule inhibitors 
directed to the MAPK/ERK and GSK3 pathways. Since 
these pathways are both stimulated by LIF and can trig-
ger cell differentiation and impair ESCs self-renewal, 
they both require inhibition [8]. It has recently been 
shown that a subpopulation of mouse ESCs express the 
ERV, MERV-L as well as a pool of transcripts normally 
expressed in two-cell (2-cell)-stage embryos, whereas 
they do not express classical pluripotency-associated 
factors like OCT4. Remarkably when isolated, these 
cells have totipotent potential instead of only pluripo-
tent potential, which means that they can differentiate 
into extra-embryonic tissues (placenta) as well as into all 
three germ layers [10]. This is in line with previous data 
showing MERV-L to be highly expressed in 2-cell stage 
mouse embryos [11] before being repressed at the blas-
tocyst stage.
In contrast to mouse ESCs, human ESC lines that have 
been derived, more closely resemble mouse epiblast stem 
cells (EpiSCs), a more advanced stage of development 
of the post-implantation embryo [12]. A lot of studies 
have focused on trying to “reset” human ESC cultures to 
a more naïve state of pluripotency in order to study this 
earlier stage of development. So far, no consensus has 
been established in terms of the optimum conditions 
for naïve human pluripotent cell culture, although three 
main protocols for generating these cells have recently 
been developed [13–15]. Some strategies require the use 
of different cocktails of small molecules inhibitors and 
cytokines to stimulate the expression of naïve pluripo-
tency proteins such as LBP9 [13, 15, 16], whereas other 
approaches employ the direct introduction of pluripo-
tency factors as transgenes to achieve the same effect 
(NANOG and KLF2 transgene expression coupled to 
ERK inhibition) [14].
However, it has recently been shown that a natural 
population of naïve-like cells exists in human ESC cul-
tures and transiently during reprogramming, and these 
cells can be isolated simply by using a GFP reporter 
driven by a HERV-H promoter, since they express this 
primate-specific retrovirus ([17–19] and see Figure  1a). 
This would obviate the need for complicated and expen-
sive culture protocols to induce naïve ESCs. Retroviruses 
such as MERV-L in mouse and HERV-H in human are 
therefore powerful tools to naturally select distinct pop-
ulations of primitive pluripotent cells in order to study 
early development and offer new perspectives in repro-
gramming strategies and in the production of stem cell 
medicines. It is clear that retrotransposons impact on cell 
fate and reprogramming but how do they do this? Their 
distinct functions can be divided into three categories 
detailed below, which are (a) the recruitment of TFs to 
activate cellular genes, (b) the production of noncoding 
RNAs and finally, (c) potential roles of viral proteins and 
particles.
(a) Retrotransposon DNAs bind core pluripotency fac-
tors in a species-specific manner Retrotransposons have 
likely evolved to recruit activating TFs expressed early 
in development to ensure their propagation through the 
germ line and overall persistence in the genome. This 
has been beneficial to the host, providing us with a pool 
of regulatory sequences that can act as novel enhancers 
and promoters [20]. The creation of new TF binding sites 
within retrotransposons has occurred similarly in both 
mice and humans, although since many retrotransposon 
types and locations are distinct between these two spe-
cies, this has led to unique gene regulatory circuits.
Several retrotransposons are abundantly expressed in 
human ESCs such as long interspersed nuclear element 
1 (LINE-1) [21] and HERV-H [18]. This tissue-specificity 
is determined in part by TFs. For example, one LINE-1 
family member, L1TD1 that has lost enzymatic activity 
is specifically expressed in ESCs because its promoter 
recruits NANOG, OCT4 and SOX2 [22]. HERV-H 
recruits the TF, LBP9 [19], and since this TF is essential 
for ground-state pluripotency [23], HERV-H, as one of 
its targets in human cells, is an integral component of 
naïve cells. LBP9 is a recent example that fits with a pre-
vious broad observation that core pluripotency TFs exert 
highly species-specific binding profiles. Indeed, it was 
established that up to 25% of pluripotency-associated 
TF binding sites were contributed from transposable ele-
ments, and that these TF-bound loci are lineage or spe-
cies-specific because of the often random nature of the 
retrotransposition process [24]. Not all TFs are recruited 
to retrotransposon sequences and it appears that 
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pluripotency associated TFs are enriched at these sites, 
although interestingly, the transcription insulator CTCF 
that is ubiquitously expressed also binds retrotrans-
posons, but in this case B2 SINEs (short-interspersed 
nuclear elements) [25]. Certain classes of retrotranspo-
sons are enriched for particular TFs: for instance, OCT4/
SOX2 binding is enriched on ERVK repeats in mouse 
and ERV1 in humans and TP53 is predominantly found 
on Mer61-type ERV1 repeats in human [26]. Sequence 
patterns that resemble binding site motifs of some TFs 
(ESR1, TP53, OCT4/SOX2, and CTCF) embedded within 
different transposable elements can therefore predispose 
them to becoming mammalian TF binding sites.
The majority of TF binding sites occur in the long ter-
minal repeats (LTRs) of retrotransposons, which flank 
open reading frames (ORFs), or on UTRs of non-LTR 
retrotransposons such as LINE and SINE elements. 
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Figure 1 HERV‑H activity overlaps with ground state pluripotency. a HERV‑H expression is thought to define naïve‑like stem cells. b Mechanism of 
HERV‑H regulation of stem cell gene expression.
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recruitment of pluripotency-associated TFs and co-fac-
tors (such as chromatin modifiers) to moderate expres-
sion of cellular genes. The influence of retrotransposons 
on gene expression is significant because local epigenetic 
modifications can exert long-range effects by remodelling 
large chromatin domains and higher order chromatin 
structure, and LTR enhancers may loop to cellular genes 
in cis or even in trans, for example through CTCF [25]. In 
human and mouse ESCs, it was recently shown that LTR-
derived enhancers affected numerous genes involved 
in chromatin organization, cell cycle and stemness [27]. 
We have also shown that repressed LTRs can become 
enhancers when they escape silencing, showing that 
silenced LTRs contain intrinsic enhancer activity and 
may act as temporal enhancers [28]. Similarly, LTRs also 
exert significant promoter effects that can be switched on 
during critical developmental stages. For instance, waves 
of stage-specific retrotransposon activation occur dur-
ing pre-implantation embryo development. Indeed, by 
investigating the transcriptomes of human pre-implan-
tation embryos, Goke and colleagues [29] have docu-
mented transient ERV activation taking place between 
the oocyte and blastocyst stages. Their analysis of differ-
ent ERV families revealed that each stage of the embryo 
expresses distinct ERV classes, for example, HERVK14 is 
only expressed between the pronucleus and 4-cell stage, 
whereas THE1A is restricted to the 8-cell and Morula 
stages. Interestingly, both elements are not expressed in 
human ESCs, reinforcing the idea that cultured human 
ESCs only represent a snapshot of development and are 
primarily not naïve ESCs [29]. Another example of a 
stage-specific ERV is MERV-L [30], whose promoters 
drive expression of hundreds of 2-cell stage expressed 
genes [10]. While retrotransposons can act as promoters 
or enhancers for cellular genes, their enhancer function is 
particularly fascinating due to the recently documented 
rapid evolution of enhancer modules across species, 
which includes enhancers derived from retrotransposon 
sequences [31].
(b) Non-coding RNAs derived from LTRs play a role in 
stem cell identity Pluripotency TF binding to retrotrans-
posons leads to transcription not only of cellular genes 
but also of retrotransposon RNAs, some of which are 
coding and many of which are short or long non-coding 
RNAs (lncRNAs) of largely unknown function. Interest-
ingly, some non-coding RNA molecules are chimeric 
because they originate from splicing events between 
cellular and viral transcripts. Of particular interest, rare 
sub-populations of human ESCs (termed naïve cells, 
introduced above) have an active chromatin configura-
tion at LTR7 sites in the genome (hypomethylated DNA, 
active histone marks and bound NANOG, OCT4, KLF4 
and LBP9) and show elevated expression of their linked 
HERV-H transcripts, as well as of HERV-K transcripts, 
([19, 27, 32] and see Figure  1b). High-throughput tran-
scriptional profiling of mouse and human stem cells has 
revealed a large pool of species-specific chimeric and 
lncRNAs, including several pluripotency-associated 
lncRNAs, such as lin-ROR [33] and linc00458 [34].
Increased expression of some members of the HERV-
H family is also observed in human induced pluripotent 
stem cells (iPSCs) [17, 35]. Depletion of some HERV-H 
expressed loci or of lin-ROR in human ESCs, using RNA 
interference, results in a drastic change in cellular mor-
phology, with cells adopting a more differentiated phe-
notype (fibroblast-like) [32]. LncRNAs are implicated in 
many cellular processes including chromatin remodel-
ling, control of promoter activity, X-chromosome inacti-
vation, imprinting and nuclear import (reviewed in [36]). 
However, the specific role of most lncRNAs remains 
unclear. In the context of stem cells, retrotransposon-
derived transcript expression levels closely mirrors the 
expression patterns of core pluripotency factors such 
as OCT4, NANOG and SOX2, suggesting that they 
might be essential to the pluripotent state. Importantly, 
HERV-H must be silenced to guarantee successful cell 
differentiation [34]. Reminiscent of pluripotent cells, 
LTR7-induced transcripts (including HERV-H lincRNA-
RoR [33], LINE-1 [37] and HERV-K [35]) are transiently 
activated during reprogramming to iPSCs, indicating 
that their role in ESCs may parallel their role in restoring 
pluripotency in differentiated cells. However, they need 
to be subsequently repressed for successful reprogram-
ming [17]. In general, high HERV-H RNA levels define 
naïve ESCs, concomitant with a complete loss of repres-
sive chromatin marks such as condensed H3K27me3, 
whereas HERV-H is only lowly detected in primed ESCs. 
Of note, a similar enrichment of ERV derived transcripts 
has also been described in trophoblast stem cells and pla-
centa [38].
However, what do HERV-H-lncRNAs do? Recent 
work has shown evidence that these RNA molecules can 
recruit transcriptional co-activators and other proteins 
into DNA-binding regulatory complexes. A specific func-
tion of long intergenic non-coding RNAs (lincRNA) was 
first demonstrated in human fibroblasts and their deriva-
tive iPSCs where a lincRNA specific microarray analysis 
was performed [33]. Additionally, RNA cross-linking 
experiments in human ESCs show that HERV-H-lncR-
NAs act as a scaffold unit that recruits the co-activators 
CBP, p300, MED6 and MED12, to enhancer regions 
[32]. These lncRNAs are also associated with OCT4, 
and are thought to play an essential role in LTR-specific 
enhancer activity (Figure 1b). For example, one of these 
co-activators is the histone acetyltransferase p300, which 
was showed to be essential for the recruitment of the 
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NANOG/OCT4/SOX2 complex and regulates transcrip-
tion via chromatin remodelling [39].
In sum, the involvement of retrotransposon lncRNAs 
in the control of pluripotency in early development and 
in reprogramming is a common mechanism in mammals, 
likely acting through RNA-recruited co-activators but 
operating via species-specific transposable elements.
(c) Viral proteins, and particles that bud from embryos 
may function in development Some of the first electron 
microscopy images of chicken embryos revealed mysteri-
ous virus-like particles (VLPs) of unknown function, which 
were mainly extracellular [40]. Likewise, in mouse embryos, 
ERVs, including of the IAP and MERV-L classes can be 
observed budding into the endoplasmic reticulum, par-
ticularly at the 2-cell stage [41]. The potential function of 
retroviral particles is unknown, although they may serve an 
antiviral role. In contrast, it is well established that certain 
retroviral proteins serve vital functions in reproduction and 
development. The best example of this is the syncytin fam-
ily: syncytins 1 and 2 are essential placental genes derived 
from retroviral envelopes. These proteins emerged in mam-
mals on at least six occasions independently and were 
retained each time by natural selection to carry out the 
same function. Syncytins are responsible for the formation 
of the syncytiotrophoblast, the multicellular element of the 
placenta responsible for nutrient exchange and shielding 
the embryo from the mother’s immune system [42].
Another documented example of retrotransposon 
protein expression is for LINE-1. It was recently dem-
onstrated that mammals have evolved to use LINE-1 
retrotransposon activity as a way to assess the quality of 
gametes. The massive loss of oocytes (two-thirds are lost 
in mice and around 80% in humans) that takes place dur-
ing their maturation serves as a key quality-control check-
point. For example, a recent study demonstrated that 
levels of the LINE-1 protein, L1ORF1p, which is essen-
tial for retrotransposition, acted as a marker to govern 
oocyte fate. Apoptosis is triggered only in oocytes with 
high L1ORF1p levels, ensuring that aberrant LINE-1 acti-
vation during epigenetic reprogramming of the genome 
remained as low as possible in the surviving oocytes and 
potential offspring [43]. An analogous mechanism likely 
exists in the male germ line. Conversely, the L1TD1 gene 
is an interesting example of a LINE-1 protein that has 
been positively selected in both primates and mice, due 
to beneficial roles it is thought to play in both genome 
defence and pluripotency [44]. Of note, active retrotrans-
position of LINE-1 has been reported in neural progenitor 
cells and brains of rodents and humans [45–48], although 
the potential function of this is unknown.
Although it is largely unknown how viral proteins 
and particles might contribute to genome defence and 
maintain pluripotent states, an exciting recent study on 
HERV-K provides new insight into these questions [49]. 
The authors reveal firstly that OCT4 drives expression of 
human-specific HERV-K proviruses by binding to their 
promoters (LTR5HS), leading to the production of GAG 
proteins and VLPs during early human development. Sec-
ondly, the HERV-K accessory protein, Rec binds to a sub-
set of cellular mRNAs and can influence their translation, 
and finally HERV-K may serve to combat exogenous viral 
infections because it is shown to upregulate classical virus 
restriction factors such as IFITM1. Of note, data from this 
paper also suggests that HERV-K may be a more accurate 
marker of naive human ESCs than HERV-H because it is 
expressed in naive but not primed human ESCs.
Part II: Retrotransposons are repressed in ESCs
KAP1 retrotransposon repression shapes gene regulation
The very retrotransposons that are active and have been 
exapted to serve useful gene regulatory functions are often 
the same families that our genomes have evolved to repress. 
This is because these families contain elements with intact 
regulatory sequences that could interfere with gene expres-
sion and/or functional open reading frames that could lead 
to retrotransposition events. One example of this is MERV-
L, which, as mentioned above, is highly abundant at the 
2-cell stage of development (contributing to 3% of mRNAs) 
but repressed by the blastocyst stage [30].
Active retrotransposon families are targeted for epige-
netic silencing early in development and during repro-
gramming [17, 35, 50]. One important repression pathway 
we and others have uncovered is the KAP1 (TRIM28) 
pathway that operates in ESCs and early embryos: KAP1 
is recruited to repetitive sequences through site-specific 
krüppel-associated box domain-containing-zinc finger 
proteins (KRAB-ZFPs) and represses them through the 
histone methyltransferase ESET/SETDB1 [51–56] (and 
reviewed in [57, 58]), leading to their subsequent DNA 
methylation [59]. ERV silencing also leads to the repres-
sion of nearby genes due to the spreading of epigenetic 
marks, suggesting that this mechanism may have been co-
opted for the fine-tuning of gene expression; certain genes 
are not switched off but maintained in a lowly expressed 
state in early development [28, 60, 61].
KAP1 repression is sequence-specific in vitro and in 
vivo [59] and retrotransposons that have more recently 
invaded the genome escape KAP1 through subtle 
changes in their nucleotide content, presumably because 
the KRAB-ZFP system has not yet adapted to repress 
them. This is true for both mouse (for example for the 
IAP class [53]) and human retrotransposons (LINE-1 
[51]), although it is best illustrated with the LINE-1 fam-
ily, due to the recent classification of LINE families based 
on their relative ages [62]. The most ancient LINE-1 
families are neither KAP1-bound nor DNA methylated, 
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presumably because they are dead by mutation, whereas 
the newer ones are KAP1-bound, repressed and highly 
DNA methylated, and finally the most recent families 
escape KAP1-repression, but they are regulated through 
DNA methylation, which may be deposited through one 
or more small RNA pathways ([51] and see Figure  2a). 
The KAP1-ERV repression pathway operates in mouse 
and human ESCs but is not required in mouse embry-
onic fibroblasts [53, 54], presumably because DNA meth-
ylation takes over as the dominant silencing mechanism 
later in development, a hypothesis we and others have 
provided evidence for [59, 63, 64]. Of interest, KAP1 
repression of ERVs is still detected in mouse neural pro-
genitor cells [65].
b
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Figure 2 Adaptive evolution of retrotransposon repression in ESCs. a Co‑evolution of retrotransposons and KRAB‑ZFPs. b Mechanism of KAP1 
repression of retrotransposons.
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KAP1 repression of retroviruses was initially discov-
ered in the context of murine leukaemia virus (MLV) 
[55], which led on from original observations that MLV 
was restricted in embryonic cells [66] through its primer 
binding site Pro (PBS-pro) sequence that binds proline 
tRNA [67, 68]. This sequence was later discovered to 
recruit KAP1 through the mouse KRAB-ZFP, Zfp809 
[56]. MLV still serves as a practical model to explore the 
KAP1 repression pathway and it was recently uncovered 
that YY1 and EBP1 contribute to an MLV silencing com-
plex [69–71], factors that may also repress ERVs with a 
PBS-pro and/or ERVs with unrelated PBS sites (reviewed 
in [72]). Elegant work has just revealed, through Zfp809 
knockout mice and genetic and biochemical experiments 
in ESCs, that Zfp809 not only restricts exogenous MLV 
but also several ERVs that contain PBS-pro sequences, 
as predicted [73]. Strikingly, in Zfp809 knockout mice, 
disruption of silent chromatin marks normally estab-
lished early in development at VL30-(virus-like 30) type 
PBS-pro ERVs leads to their overexpression in differenti-
ated tissues, together with nearby genes. Of note, VL30 
elements lack coding regions, illustrating how KAP1 
represses not only coding but also non-coding ERVs that 
remain a threat because of their regulatory sequences. 
This new study, therefore, provides conclusive evidence 
that the KAP1/KRAB-ZFP pathway is necessary to 
repress retrotransposons and linked genes in vivo.
Human retrotransposons are targeted by human‑adapted 
KRAB‑ZFPs
The finding that KAP1 represses multiple classes of ERVs 
(mainly IAPs and MERVK in mouse [53] or HERVK and 
LINE-1 in humans [54], most of which do not operate 
through a PBS-pro or even have mutated PBS sequences 
or no PBS sequence (LINE-1s), led to the concept that 
retrotransposons may recruit KAP1 through a multitude 
of different site-specific KRAB-ZFPs. This would ensure 
that even retrotransposons that cannot reverse tran-
scribe are maintained inactive so as not to affect cellular 
genes through their potentially active enhancer/promoter 
sequences [28, 60]. This is supported by the diverse 
KRAB-ZFPs that our genomes encode, many of which 
are species-specific and rapidly evolving with largely 
unknown functions, which suggests their participation 
in genetic conflict with viral sequences that are also rap-
idly evolving [74–78]. One example of KRAB-ZFP adap-
tive evolution is the ZNF91 subfamily that has expanded 
across primate lineages [79].
However, while previously only a model, it has not been 
until now that exciting work has illustrated that indeed 
our genomes do encode a repertoire of KRAB-ZFPs 
adapted to recognize and target species-specific retro-
transposons. Specifically, the human proteins ZNF91 and 
ZNF93 bind to and repress SVA and LINE-1 retrotrans-
posons respectively, in the human genome [80]. SVA ele-
ments are a newly emerged retrotransposon class that 
invaded great ape genomes 18–25 million years (myr) 
ago. They are composite retrotransposons that contain 
an Alu-like fragment that is joined by a variable number 
tandem repeat (VNTR) domain to a SINE region that 
contains 3′LTR sequences similar to the ERV, HERV-K10 
[81]. ZNF91 underwent structural changes between 8 
and 12 myr ago to restrict SVAs, including the addition 
of seven zinc fingers. The authors nicely link structure to 
function showing that while macaque ZNF91 is unable to 
repress a human SVA reporter plasmid in mouse ESCs, 
(which do not express endogenous ZNF91), transfected 
human ZNF91 with its seven newly evolved zinc fingers 
induces strong SVA repression, as expected [80].
ZNF93 is another interesting example of a host-ret-
rotransposon interaction, particularly because LINE-1s 
exert a unique pattern of evolution with a single L1PA 
subfamily active at one time in a genome before being 
replaced by a new subfamily, allowing their approximate 
ageing [62]. For example, in the human genome, L1PA4 
(18 myr old) was replaced by L1PA3 (15.8 myr old), which 
was replaced by L1PA2 (7.6 myr old). KRAB-ZFP evolu-
tion relates to the activity of LINE-1 subfamilies because 
ZNF93 targets a sequence present in the L1PA4 UTRs 
and some L1PA3 UTRs but which is deleted in L1PA2 
elements leading to their escape from ZNF93 repression 
in mouse ESCs when LINE-1 reporters and ZNFs are 
co-transfected [80]. ZNF93 underwent zinc finger dele-
tions and other structural adaptations to repress human 
LINE-1s. As such, human ZNF93 but not macaque 
ZNF93 is able to repress an L1PA4 reporter construct 
in mouse ESCs. In the case of SVAs, nearby genes were 
also repressed through ZNF91, which supports previ-
ous findings that retrotransposon repression can lead to 
species-specific fine-tuning of gene circuits in vitro [28, 
60] and in vivo [73]. Species-specificity is driven not only 
by LINEs and SVAs, some of which are distinct in the 
human genome but also by the TFs they recruit, which 
are also species-specific, as they have undergone adapta-
tion between primate lineages. These new findings lead 
us to a summary model of KAP1 repression of retrotrans-
posons, although the exact enzymes required are still 
unclear (See Figure 2b).
Of note, still only a handful of KRAB-ZFPs that recog-
nise repetitive DNA have been characterized to date. This 
includes the two human KRAB-ZFPs discussed above 
and the mouse KRAB-ZFP Zfp809, already mentioned 
[55, 56, 73]. Apart from these, an additional mouse 
KRAB-ZFP, Zfp819 has been implicated in modulating 
expression of IAP ERVs and LINEs through an unknown 
sequence, which impacts on the balance between 
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pluripotency and differentiation [82] and the new mouse 
KRAB-ZFP Gm6871 that was previously only a predicted 
gene, targets a subset of LINEs (mainly of the L1MdF2 
family), again through a 5′UTR sequence [51]. A mouse 
KRAB-ZFP Ssm1b has also been implicated in DNA 
methylation of foreign DNA [83]. Many questions per-
sist concerning how KRAB-ZFPs exert their functions, 
their patterns of evolution, how many of them recognise 
repetitive sequences, where and when they act, how they 
impact on cellular genes and how they relate to disease 
settings. However, a recent paper provides evidence that 
most KRAB-ZFPs may target repetitive sequences since 
16 out of 18 human KRAB-ZFPs sampled at random 
bound repeated elements, including LINE-1, HERVs and 
SVAs, as determined by chromatin immunoprecipita-
tion [84]. Of note, the authors also used high throughput 
binding data to create an improved ZFP recognition code 
predictor.
Other retrotransposon repression pathways
While a discussion of all other potential retrotransposon 
repression pathways acting within ESCs is beyond the 
scope of this review, we mention a few of the main ones 
below and refer to other reviews [72, 85]. These can be 
divided into transcriptional repression pathways, which 
together with KAP1 act as the first line of defence against 
retrotransposons, and post-transcriptional repression 
pathways that are crucial at later stages of the retrotrans-
poson life cycle to prevent new retrotransposition events.
Transcriptional repression pathways involving histone 
deacetylases and histone methyltransferases/demethy-
lases are fundamental to retrotransposon repression in 
ESCs because in these cells, there is a layer of repres-
sion additional to DNA methylation, highlighted by the 
finding that triple knockout of DNMT1, DNMT3a and 
DNMT3b is not sufficient to significantly reactivate ret-
rotransposons such as IAPs [63, 86]. DNA methylation-
independent mechanisms of repression are presumably 
required in development in the face of global re-setting 
of the epigenome. Key enzymes implicated in retrotrans-
poson repression in ESCs include HDACs [87, 88], ESET/
SETDB1 [52, 59, 89], which likely has KAP1-independent 
as well as dependent targets, LSD1/KDM1a [90], G9a 
[91], Suv420H1/2 that mediates H4K20me3 [28, 52], 
polycomb complexes [92] and Suv39h [93]. Other less 
studied enzymes such as the arginine methyltransferase 
PRMT5 may also play a role, since it has recently been 
uncovered to interact with KAP1 [94] and repress some 
retrotransposons in primordial germ cells and preimplan-
tation embryos during DNA methylation reprogramming 
[95]. The role of PRMT5 in retrotransposon repression 
was also assessed in prmt5 deleted and control 2i- cul-
tured ESCs (see ESC culture protocols in part I above), 
which display DNA hypomethylation, but only 1.8-fold 
of IAP-Gag upregulation was observed in this context, 
perhaps due to PRMT5 compensation by PRMT7. Other 
co-factors that have been implicated in retrotransposon 
transcriptional repression include HP1 family members 
that interact with KAP1 [96–98] and may be involved 
in long-range repression [99, 100], DNMT3L [101, 102], 
hnRNPK and MCAF1 [103], REX1 [104, 105] and SIRT6 
[106]. Exactly which enzymes are directed to certain ret-
rotransposons and how and when KAP1 is involved is 
unknown. It is possible that non-coding RNAs play a tar-
geting role in a similar way to how they tether co-activa-
tors to HERV-H (see part I above).
Post-transcriptional repression pathways include 
intrinsic factors that block later stages of the retrotrans-
poson lifecycle such as SAMHD1 ([107] and see [108] for 
a review). A multitude of small RNA pathways are cru-
cial to retrotransposon regulation in development and 
the intricate details of these pathways are only now being 
unravelled. Some small RNAs like piRNAs (small non-
coding piwi-interacting RNAs) can even induce the silent 
histone mark H3K9me3 and de novo DNA methylation 
at least in the germ line, adding to transcriptional silenc-
ing [50, 109–111] and the piRNA pathway may play a role 
in ESCs [112]. Interestingly, small RNAs derived from 
LINE-1 have been implicated in transcriptional activa-
tion of LINE-1 at the 2-cell stage of embryo development 
[113], whereas in mouse ESCs, there is a role for small 
RNAs in LINE-1 restriction because there is an increase 
in LINE-1 transcripts in Dicer knockout ESCs that is 
rescued by ectopic Dicer expression [114]. Still much is 
unknown about small RNA transposon silencing in ESCs, 
particularly as small RNAs detected (in this case from 
LINE-1) include both Dicer-dependent and independent 
classes [114].
Discussion and perspectives
As discussed, retrotransposons can confer regulatory 
complexity to gene networks early in development and 
in ESCs by serving as enhancers and/or promoters of 
key developmental genes. They provide new regulatory 
sequences that have been integrated into novel gene net-
works and they are particularly important in the main-
tenance of the naïve pluripotent cell state, likely through 
their adaptation to bind TFs expressed early in develop-
ment (see [72, 85, 115, 116] for additional reviews on this 
topic).
Many questions remain about the extent to which a 
family of retrotransposons can be repressed or activated 
in certain tissues or at particular developmental stages, 
and which factors coordinate switches in activation sta-
tus. One interesting perspective is that the very KRAB-
ZFP pathways that repress retrotransposons may actually 
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only induce temporal or tissue-specific repression, and 
there is some evidence for KRAB-ZFPs even being activa-
tors in some cases [76]. It would make sense for the host 
to evolve to restrict retrotransposons in situations where 
they pose heritable threats to the germ line such as in 
germ cells or early embryos where many KRAB-ZFPs are 
enriched. This may have led to retrotransposons becom-
ing ideal lineage-specific enhancers that get switched on 
during later stages of development, a hypothesis worth 
exploring. Another interesting perspective is that since 
KRAB-ZFP gene clusters are heavily intermingled with 
retrotransposons, some of them may have been reverse 
transcribed along with retrotransposons, which may have 
contributed to their rapid evolution and increase in copy 
number.
In summary, retrotransposons are, unlike classical 
viruses, essential to the evolution of our genomes and 
have contributed to genome plasticity and the creation of 
new genes. We can use them as tools to direct cell fate 
and reprogramming but studying their intricate pathways 
of expression is necessary to understand gene regulation 
in development, and to develop safe stem cell medicines. 
Research into this topic is particularly relevant to under-
standing and treating genetic diseases and cancers in 
which retrotransposons have been implicated.
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